ACTC's Rabin and Matt Vicent stated China's joint venture is in advanced state of discussion negotiation. I'm thinking the deal will get done sometime before the end of the year.
Reverse split before July.
20% improvement in eye vision with the injection of 50,000 stem cells. What will be in the % improvement with 100,000 stem cells, that will be what the next patients will get.
There conference call gave me the confidence to buy more shares.
With a joint venture, published results and ensuing media coverage for SMD [any day] and Dry AMD [June] this will be a 10 bagger.
Geron was up 3 cents and closed at $1.73 volume was 405,346. The three month avg. volume is 892,535. Waiting for the deal. Waiting for results.
Good luck in this rigged casino,
No comments:
Post a Comment